Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 13 studies | 24% ± 10% | |
macrophage | 12 studies | 32% ± 15% | |
myeloid cell | 8 studies | 26% ± 7% | |
alveolar macrophage | 7 studies | 19% ± 4% | |
naive B cell | 7 studies | 20% ± 5% | |
conventional dendritic cell | 6 studies | 31% ± 15% | |
basal cell | 5 studies | 25% ± 5% | |
B cell | 5 studies | 20% ± 4% | |
dendritic cell | 4 studies | 33% ± 10% | |
mast cell | 4 studies | 29% ± 15% | |
monocyte | 3 studies | 23% ± 5% | |
extravillous trophoblast | 3 studies | 40% ± 10% | |
memory B cell | 3 studies | 18% ± 1% | |
plasmacytoid dendritic cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 21% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 100% | 8166.95 | 1809 / 1809 | 100% | 153.34 | 472 / 472 |
uterus | 99% | 2496.94 | 169 / 170 | 100% | 147.55 | 459 / 459 |
brain | 99% | 3095.42 | 2616 / 2642 | 100% | 92.36 | 704 / 705 |
prostate | 99% | 2623.23 | 243 / 245 | 100% | 71.31 | 500 / 502 |
breast | 99% | 2823.18 | 454 / 459 | 100% | 98.08 | 1116 / 1118 |
bladder | 100% | 3421.95 | 21 / 21 | 99% | 108.08 | 497 / 504 |
lung | 99% | 4301.52 | 573 / 578 | 99% | 128.38 | 1145 / 1155 |
intestine | 100% | 2637.69 | 963 / 966 | 98% | 59.35 | 519 / 527 |
ovary | 99% | 2380.19 | 179 / 180 | 99% | 47.05 | 424 / 430 |
esophagus | 100% | 4934.88 | 1439 / 1445 | 98% | 108.65 | 180 / 183 |
adrenal gland | 100% | 3936.00 | 258 / 258 | 90% | 51.25 | 208 / 230 |
stomach | 91% | 1517.84 | 327 / 359 | 98% | 59.96 | 281 / 286 |
thymus | 91% | 1451.62 | 593 / 653 | 98% | 50.45 | 594 / 605 |
pancreas | 75% | 978.53 | 247 / 328 | 99% | 72.38 | 176 / 178 |
kidney | 76% | 1162.47 | 68 / 89 | 97% | 88.92 | 876 / 901 |
liver | 74% | 1012.27 | 167 / 226 | 96% | 50.08 | 390 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 78.40 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 318.83 | 29 / 29 |
spleen | 100% | 4366.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 214.63 | 45 / 45 |
adipose | 99% | 2916.63 | 1191 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 2535.81 | 1314 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 6287.01 | 908 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 2216.74 | 780 / 861 | 0% | 0 | 0 / 0 |
muscle | 21% | 220.81 | 167 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007611 | Biological process | learning or memory |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0051651 | Biological process | maintenance of location in cell |
GO_0046479 | Biological process | glycosphingolipid catabolic process |
GO_0019915 | Biological process | lipid storage |
GO_0009313 | Biological process | oligosaccharide catabolic process |
GO_0006869 | Biological process | lipid transport |
GO_0006689 | Biological process | ganglioside catabolic process |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005576 | Cellular component | extracellular region |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0016323 | Cellular component | basolateral plasma membrane |
GO_0016004 | Molecular function | phospholipase activator activity |
GO_0030290 | Molecular function | sphingolipid activator protein activity |
GO_0005319 | Molecular function | lipid transporter activity |
GO_0032428 | Molecular function | beta-N-acetylgalactosaminidase activity |
Gene name | GM2A |
Protein name | Alternative protein GM2A Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short] Ganglioside GM2 activator |
Synonyms | |
Description | FUNCTION: The large binding pocket can accommodate several single chain phospholipids and fatty acids, GM2A also exhibits some calcium-independent phospholipase activity (By similarity). Binds gangliosides and stimulates ganglioside GM2 degradation. It stimulates only the breakdown of ganglioside GM2 and glycolipid GA2 by beta-hexosaminidase A. It extracts single GM2 molecules from membranes and presents them in soluble form to beta-hexosaminidase A for cleavage of N-acetyl-D-galactosamine and conversion to GM3 (By similarity). Has cholesterol transfer activity . . |
Accessions | ENST00000357164.4 H0YBY3 E5RJD0 L0R4Y4 ENST00000523466.5 ENST00000523004.1 P17900 |